These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37741147)

  • 1. Biological and physico-chemical characterization of human norovirus-like particles under various environmental conditions.
    Abou-Hamad N; Estienney M; Chassagnon R; Bon M; Daval-Frerot P; de Rougemont A; Guyot S; Bouyer F; Belliot G
    Colloids Surf B Biointerfaces; 2023 Nov; 231():113545. PubMed ID: 37741147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Norovirus Binding Patterns in Nonsecretor Individuals.
    Tarris G; Estienney M; Daval-Frérot P; Lariotte AC; Aubignat D; Sé K; Michiels C; Martin L; de Rougemont A; Belliot G
    J Virol; 2022 Oct; 96(19):e0086522. PubMed ID: 36121297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
    Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
    Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
    Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
    Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
    Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
    Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012.
    Ge L; Chen X; Liu J; Zheng L; Chen C; Luo S; Guo P; Kong J; Song Y; Huo Y
    Virus Genes; 2020 Apr; 56(2):174-181. PubMed ID: 31912284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
    Debbink K; Donaldson EF; Lindesmith LC; Baric RS
    J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
    Huo Y; Zheng L; Chen X; Ge L; Wang Y
    Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of GII.4 norovirus persistence in human populations.
    Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
    PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
    Koromyslova AD; Morozov VA; Hefele L; Hansman GS
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor profile and immunogenicity of the non-epidemic norovirus GII.8 variant.
    Gao J; Xue L; Liang Y; Wang L; He F; Meng L; Cai W; Zhang J; Wang J; Ye Q; Wu S; Gu Q; Wu Q
    Virus Res; 2021 Dec; 306():198603. PubMed ID: 34662679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
    Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
    J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles.
    Devant JM; Hofhaus G; Bhella D; Hansman GS
    Antiviral Res; 2019 Aug; 168():175-182. PubMed ID: 31145925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable High-Pressure-Processing Sensitivities for Genogroup II Human Noroviruses.
    Lou F; DiCaprio E; Li X; Dai X; Ma Y; Hughes J; Chen H; Kingsley DH; Li J
    Appl Environ Microbiol; 2016 Oct; 82(19):6037-45. PubMed ID: 27474724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses.
    Ettayebi K; Salmen W; Imai K; Hagi A; Neill FH; Atmar RL; Prasad BVV; Estes MK
    mBio; 2022 Apr; 13(2):e0284821. PubMed ID: 35297675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cells.
    Carmona-Vicente N; Allen DJ; Rodríguez-Díaz J; Iturriza-Gómara M; Buesa J
    Virol J; 2016 May; 13():82. PubMed ID: 27206610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human noroviruses' fondness for histo-blood group antigens.
    Singh BK; Leuthold MM; Hansman GS
    J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive characterization of a major capsid protein derived from a documented GII.6 norovirus strain.
    Zheng L; Wang W; Liu J; Huo Y; Qin C; Wang M; Shen S
    Arch Virol; 2017 Dec; 162(12):3863-3868. PubMed ID: 28866835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.